ABEO insider transaction filings
ABEONA THERAPEUTICS INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-22. Screen ABEO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-22 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 1,478 @ $6.53 | EDGAR |
| 2026-07-09 | 4 | Vasanthavada Madhav — Chief Commercial Officer | Sale (S): 12,606 @ $6.96 | EDGAR |
| 2026-07-09 | 4 | O'Malley Brendan M. — SVP, Chief Legal Officer | Sale (S): 12,050 @ $6.96 | EDGAR |
| 2026-07-09 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 67,971 @ $6.96 | EDGAR |
| 2026-07-09 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 24,880 @ $6.96 | EDGAR |
| 2026-07-02 | 4 | Alland Leila — Director | Sale (S): 11,000 @ $5.92 | EDGAR |
| 2026-06-17 | 4 | Vasanthavada Madhav — Chief Commercial Officer | Other (J): 222 @ $5.67 | EDGAR |
| 2026-06-15 | 4 | Silverstein Christine Berni — Director | Sale (S): 18,160 @ $5.71 | EDGAR |
| 2026-06-09 | 4 | Vasanthavada Madhav — Chief Commercial Officer | Sale (S): 4,170 @ $5.43 · Sale (S): 5,450 @ $5.30 | EDGAR |
| 2026-06-09 | 4 | O'Malley Brendan M. — SVP, Chief Legal Officer | Sale (S): 4,826 @ $5.43 · Sale (S): 6,305 @ $5.30 | EDGAR |
| 2026-06-09 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 24,428 @ $5.43 · Sale (S): 31,916 @ $5.30 | EDGAR |
| 2026-06-09 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 10,271 @ $5.43 · Sale (S): 13,421 @ $5.30 · Sale (S): 25,646 @ $5.39 | EDGAR |
| 2026-05-26 | 4 | Alvino Mark — Director | Gift (G): 500 @ $0 | EDGAR |
| 2026-05-22 | 4 | Alvino Mark — Director | Sale (S): 6,500 @ $5.46 | EDGAR |
| 2026-05-15 | 4 | Crombez Eric — Director | Sale (S): 26,143 @ $5.53 | EDGAR |
| 2026-05-11 | 4 | Vasanthavada Madhav — Chief Commercial Officer | Sale (S): 5,548 @ $5.96 | EDGAR |
| 2026-04-07 | 4 | Goldan Keith A. — Director | Grant/award (A): 32,751 @ $0 | EDGAR |
| 2026-03-31 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 29,985 @ $4.38 | EDGAR |
| 2026-03-16 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 785 @ $4.76 | EDGAR |
| 2026-02-04 | 4 | Silverstein Christine Berni — Director | Sale (S): 20,070 @ $5.09 | EDGAR |
| 2026-02-02 | 4 | Wuchterl Donald A. — Director | Sale (S): 14,814 @ $5.09 | EDGAR |
| 2026-02-02 | 4 | Alland Leila — Director | Sale (S): 18,065 @ $5.09 | EDGAR |
| 2026-02-02 | 4 | Crombez Eric — Director | Sale (S): 16,284 @ $5.09 | EDGAR |
| 2026-02-02 | 4 | Alvino Mark — Director | Sale (S): 2,000 @ $5.09 | EDGAR |
| 2026-01-27 | 4 | Zeiher Bernhardt G — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Wuchterl Donald A. — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Charles Faith L. — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Amoroso Michael — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Alland Leila — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Silverstein Christine Berni — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Crombez Eric — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-27 | 4 | Alvino Mark — Director | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2026-01-26 | 4 | Vasanthavada Madhav — Chief Commercial Officer | Grant/award (A): 76,621 @ $0 · Sale (S): 12,610 @ $5.29 | EDGAR |
| 2026-01-22 | 4 | O'Malley Brendan M. — SVP, Chief Legal Officer | Sale (S): 13,578 @ $5.33 | EDGAR |
| 2026-01-22 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 69,832 @ $5.33 | EDGAR |
| 2026-01-22 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 18,666 @ $5.33 | EDGAR |
| 2026-01-21 | 4 | Alvino Mark — Director | Sale (S): 13,500 @ $5.23 | EDGAR |
| 2026-01-20 | 4 | O'Malley Brendan M. — SVP, Chief Legal Officer | Grant/award (A): 113,949 @ $0 | EDGAR |
| 2026-01-20 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Grant/award (A): 365,422 @ $0 | EDGAR |
| 2026-01-20 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Grant/award (A): 133,595 @ $0 | EDGAR |
| 2025-12-29 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 25,000 @ $5.31 | EDGAR |
| 2025-11-14 | 4 | Alvino Mark — Director | Sale (S): 15,000 @ $4.74 | EDGAR |
| 2025-10-16 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 249 @ $5.49 | EDGAR |
| 2025-10-01 | 4 | O'Malley Brendan M. — SVP, Chief Legal Officer | Sale (S): 9,366 @ $5.39 | EDGAR |
| 2025-10-01 | 4 | Seshadri Vishwas — Chief Executive Officer, Director | Sale (S): 19,274 @ $5.39 · Sale (S): 25,000 @ $5.24 | EDGAR |
| 2025-10-01 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 9,035 @ $5.39 | EDGAR |
| 2025-09-22 | 4 | O'Malley Brendan M. — SVP, Chief Legal Officer | Sale (S): 688 @ $5.43 | EDGAR |
| 2025-08-15 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 15,000 @ $7.36 | EDGAR |
| 2025-08-15 | 4 | Crombez Eric — Director | Sale (S): 4,718 @ $6.93 | EDGAR |
| 2025-07-22 | 4 | Vazzano Joseph Walter — Chief Financial Officer | Sale (S): 1,502 @ $6.64 | EDGAR |
Recent 8-K events — ABEONA THERAPEUTICS INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ABEO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →